Clinical Trials Browser

Bone Diseases × cabozantinib × Plasma cell × Clear all

NCT01582295 2017-05-25

XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease

Phase 1 Completed

Bone Diseases, Multiple Myeloma